{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:23:20Z","timestamp":1788272600503,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"am","delay-in-days":249,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100023993","name":"North Carolina Policy Collaboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019480","name":"North Carolina General Assembly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bmc.2025.118243","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:50:37Z","timestamp":1747741837000},"page":"118243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Exploration of 4\u2032-fluoro fleximer nucleoside analogues as potential broad-spectrum antiviral agents"],"prefix":"10.1016","volume":"128","author":[{"given":"Kyle A.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meareg","family":"Amare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan V.","family":"Diefenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Halfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Sheahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec J.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Seley-Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118243_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.antiviral.2018.11.016","article-title":"The evolution of antiviral nucleoside analogues: A review for chemists and non-chemist. Part II: complex modifications to the nucleoside scaffold","volume":"162","author":"Mk","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2025.118243_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","article-title":"The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold","volume":"154","author":"Seley-Radtke","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2025.118243_b0015","doi-asserted-by":"crossref","first-page":"10380","DOI":"10.1021\/acs.jmedchem.0c00935","article-title":"Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of AL-611 as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C","volume":"63","author":"Wang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0020","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1021\/acs.jmedchem.9b00143","article-title":"Synthesis and Anti-HCV Activities of 4\u2032-Fluoro-2\u2032-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4\u2032-Fluoro-2\u2032-C-methyluridine 5\u2032-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection","volume":"62","author":"Wang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/acs.accounts.1c00697","article-title":"4\u2032-Modified Nucleosides for Antiviral Drug Discovery: Achievements and Perspectives","volume":"55","author":"Chang","year":"2022","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmc.2025.118243_b0030","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1021\/jacs.9b13207","article-title":"4\u2032-Fluorinated RNA: Synthesis, Structure, and Applications as a Sensitive 19F NMR Probe of RNA Structure and Function","volume":"142","author":"Li","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118243_b0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1039\/D2CS00762B","article-title":"4\u2032-Fluoro-nucleosides and nucleotides: from nucleocidin to an emerging class of therapeutics","volume":"52","author":"Lowe","year":"2023","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmc.2025.118243_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00133-22","article-title":"Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs)","volume":"66","author":"Diamond","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118243_b0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2533\/chimia.2022.409","article-title":"Comparison of the Old and New - Novel Mechanisms of Action for Anti-coronavirus Nucleoside Analogues","volume":"76","author":"Thames","year":"2022","journal-title":"Chimia"},{"key":"10.1016\/j.bmc.2025.118243_b0050","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.3390\/cimb45080433","article-title":"Recent Advances in Molecular Mechanisms of Nucleoside Antivirals","volume":"45","author":"Kamzeeva","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.bmc.2025.118243_b0055","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1128\/AAC.01703-13","article-title":"Effects of Substitutions at the 4\u2032 and 2 Positions on the Bioactivity of 4\u2032-Ethynyl-2-Fluoro-2\u2032-Deoxyadenosine","volume":"57","author":"Kirby","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118243_b0060","series-title":"For the Treatment of HCV Infection","article-title":"Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626)","author":"Klumpp","year":"2011"},{"key":"10.1016\/j.bmc.2025.118243_b0065","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmc.2025.118243_b0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.antiviral.2017.06.011","article-title":"4\u2032-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency","volume":"144","author":"Hotard","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2025.118243_b0075","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide Prodrug Technology: From the Concept to the Clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0080","doi-asserted-by":"crossref","unstructured":"Seley-Radtke, K. L.; Kutz, C. H. M.; Thames, J. E. Flex-Nucleosides: A Strategic Approach to Antiviral Therapeutics. In Handbook of Chemical Biology of Nucleic Acids, Springer Nature Singapore, 2023; pp 2037-2106.","DOI":"10.1007\/978-981-19-9776-1_67"},{"key":"10.1016\/j.bmc.2025.118243_b0085","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JVI.02841-13","article-title":"Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir","volume":"88","author":"Chen","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2025.118243_b0090","doi-asserted-by":"crossref","unstructured":"Low, J. G. H.; Ooi, E. E.; Vasudevan, S. G. Current Status of Dengue Therapeutics Research and Development. J Infectious Diseases 2017, 215, S96-S102. DOI: 10.1093\/infdis\/jiw423 (accessed 2025-03-08T01:15:23).","DOI":"10.1093\/infdis\/jiw423"},{"key":"10.1016\/j.bmc.2025.118243_b0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118243_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204974","article-title":"Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects","volume":"13","author":"Mcclure","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118243_b0105","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1021\/jm950605j","article-title":"Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite","volume":"39","author":"McGuigan","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0110","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1021\/jm060776w","article-title":"Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives","volume":"49","author":"McGuigan","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0115","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618775243","article-title":"Phosphoramidates and phosphonamidates (ProTides) with antiviral activity","volume":"26","author":"Slusarczyk","year":"2018","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.bmc.2025.118243_b0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0008-6215(00)00089-6","article-title":"Fluorinated nucleosides","volume":"327","author":"Pankiewicz","year":"2000","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmc.2025.118243_b0125","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.3390\/molecules29102390","article-title":"Synthesis of Fluorinated Nucleosides\/Nucleotides and Their Antiviral Properties","volume":"29","author":"Kothapalli","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118243_b0130","doi-asserted-by":"crossref","unstructured":"S, M.-M.; GF, D.; A, D.-V.; P, L.; T, I.; G, P.; M, O.; MA, P.; C, G.; MJ, D. Synthesis and properties of 2'-deoxy-2',4'-difluoroarabinose-modified nucleic acids. J Org Chem. 2015, 80, 3083-3091.","DOI":"10.1021\/jo502948t"},{"key":"10.1016\/j.bmc.2025.118243_b0135","doi-asserted-by":"crossref","unstructured":"HJ, B.; D, B.; S, B.; M, K.; B, K.; K, M.; U, O.-S.; M, S. \u2013 Fluorine in medicinal chemistry. Chembiochem 5, 637-643.","DOI":"10.1002\/cbic.200301023"},{"key":"10.1016\/j.bmc.2025.118243_b0140","doi-asserted-by":"crossref","unstructured":"NA, M.; Id, O. - Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for. J Med Chem 61 (14), 5822-5880.","DOI":"10.1021\/acs.jmedchem.7b01788"},{"key":"10.1016\/j.bmc.2025.118243_b0145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jfluchem.2008.06.007","article-title":"Fluorinated nucleosides: Synthesis and biological implication","volume":"129","author":"Liu","year":"2008","journal-title":"J Fluor Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0150","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae331","article-title":"2\u2032-Fluorinated nucleoside chemistry for new drug discovery: achievements and prospects","volume":"11","author":"Meng","year":"2024","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.bmc.2025.118243_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28113-1","article-title":"A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase","volume":"13","author":"Shannon","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2025.118243_b0160","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02479-20","article-title":"AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118243_b0165","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/jo048218h","article-title":"Molecular Chameleons\u201d. Design and Synthesis of a Second Series of Flexible Nucleosides","volume":"70","author":"Seley","year":"2005","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0170","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1021\/ol0165443","article-title":"\u201cFleximers\u201d. Design and synthesis of two novel split nucleosides","volume":"3","author":"Seley","year":"2001","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2025.118243_b0175","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1021\/jo0255476","article-title":"\u201cFleximers\u201d. Design and synthesis of a new class of novel shape-modified nucleosides","volume":"67","author":"Seley","year":"2002","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/ol047895v","article-title":"\u201cMolecular Chameleons\u201d. Design and Synthesis of C-4-Substituted Imidazole Fleximers","volume":"7","author":"Seley","year":"2005","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2025.118243_b0185","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0960-894X(03)00331-7","article-title":"Unexpected inhibition of S-adenosyl-L-homocysteine hydrolase by a guanosine nucleoside","volume":"13","author":"Seley","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118243_b0190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1021\/jp046957w","article-title":"How Flexible Are Fleximer Nucleobases? A Computational Study","volume":"109","author":"Bardon","year":"2005","journal-title":"J Phys Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0195","doi-asserted-by":"crossref","first-page":"13172","DOI":"10.1021\/bi051288d","article-title":"Identification of catalytic amino acids in the human GTP fucose pyrophosphorylase active site","volume":"44","author":"Quirk","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118243_b0200","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1021\/bi0503605","article-title":"Substrate discrimination by the human GTP fucose pyrophosphorylase","volume":"44","author":"Quirk","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118243_b0205","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.bmcl.2015.05.039","article-title":"Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity","volume":"25","author":"Peters","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118243_b0210","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.bmcl.2017.04.069","article-title":"Flex-nucleoside analogues \u2013 Novel therapeutics against filoviruses","volume":"27","author":"Yates","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115713","article-title":"Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro","volume":"28","author":"Thames","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118243_b0220","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.3390\/molecules24173184","article-title":"Probing the Effects of Pyrimidine Functional Group Switches on Acyclic Fleximer Analogues for Antiviral Activity","volume":"24","author":"Yates","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118243_b0225","series-title":"Discovery and Synthesis of GS-7682, a Novel Prodrug of a 4\u2032-CN-4-Aza-7,9-Dideazaadenosine-C-Nucleoside with Broad-Spectrum Potency Against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys","author":"Siegel","year":"2024"},{"key":"10.1016\/j.bmc.2025.118243_b0230","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/jo00880a018","article-title":"4'-Substituted nucleosides. 3. Synthesis of some 4'-fluorouridine derivatives","volume":"41","author":"Owen","year":"1976","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bmc.2025.118243_b0235","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1021\/jacs.9b13207","article-title":"4\u2032-Fluorinated RNA: Synthesis, Structure, and Applications as a Sensitive <sup>19<\/sup>F NMR Probe of RNA Structure and Function","volume":"142","author":"Li","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118243_b0240","doi-asserted-by":"crossref","first-page":"20113","DOI":"10.1039\/C9RA01754B","article-title":"Microwave-assisted organic synthesis of nucleoside ProTide analogues","volume":"9","author":"Bordoni","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118243_b0245","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.0708057105","article-title":"Generation of biologically contained Ebola viruses","volume":"105","author":"Halfmann","year":"2008","journal-title":"Proc Natl Acad Sci"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:37:38Z","timestamp":1775097458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625001841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"alternative-id":["S0968089625001841"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118243","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of 4\u2032-fluoro fleximer nucleoside analogues as potential broad-spectrum antiviral agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118243"}}